
S926 Effects of Immune Modifying Therapies on Antibody Responses Following SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease
Author(s) -
Gil Melmed,
Gregory J. Botwin,
Ziad Younis,
Douglas C. Wolf,
Michael Chiorean,
Erica Cohen,
Brigid S. Boland,
Ann Flynn,
David Fudman,
Jason K. Hou,
Mark Lazarev,
Donald Lum,
Mark Mattar,
Ryan McConnell,
Arthur Ostrov,
Nimisha Parekh,
Laura E. Raffals,
Sarah Sheibani,
Corey A. Siegel,
John F. Valentine,
Bradley Morganstern,
Arash Horizon,
Swamy Venuturupalli,
Daniel J. Wallace,
Sarah C. Glover,
Adam C. Ehrlich,
Christina Ha,
Gaurav Syal,
Rashmi Kumar,
Keren Appel,
Angela Mujukian,
Shervin Rabizadeh,
Edward J. Feldman,
Theodore Stein,
Susan Cheng,
Susan Cheng,
Kimia Sobhani,
Jonathan Braun,
Dermot McGovern
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000777236.08128.73
Subject(s) - medicine , immunology , antibody , vaccination , inflammatory bowel disease , immune system , antibody titer , vedolizumab , disease , titer